AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
BH-A
Biglari Holdings Inc.
There isn't enough reported data to score BH-A yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BH-A Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
BH-A's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
BH-A PE Valuation
BH-A has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BH-A Forward outlook
There aren't enough analyst estimates for BH-A to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
BH-A Earnings Per Share
BH-A and AMZN do not have enough comparable growth data to identify a winner.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BH-A on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BH-A on profitability, with a higher operating margin.
BH-A Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.1M | +12% |
| Q2 2026 | $108.5M | +7.9% |
| Q1 2026 | $97.5M | +2.6% |
| Q4 2025 | $99.9M | +9.6% |
| Q3 2025 | $99.7M | +10% |
| Q2 2025 | $100.6M | +10% |
| Q1 2025 | $95M | +6.2% |
| Q4 2024 | $91.1M | +0.5% |
BH-A's revenue has grown year over year for eight quarters in a row: $112M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.8% | +1.9 points |
| Q2 2026 | 5.8% | +2.1 points |
| Q1 2026 | -4.3% | -15 points |
| Q4 2025 | -1.7% | -6 points |
| Q3 2025 | 6.9% | +3.3 points |
| Q2 2025 | 3.6% | -18 points |
| Q1 2025 | 11% | +4.1 points |
| Q4 2024 | 4.3% | +0.1 points |
BH-A's operating margin was 8.8% last quarter, up 1.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BH-A Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.2M | -114% |
| Q2 2026 | $8.3M | -79% |
| Q1 2026 | $13.4M | +57% |
| Q4 2025 | $6.4M | -42% |
| Q3 2025 | $22.3M | +505% |
| Q2 2025 | $39.4M | +$49.5M |
| Q1 2025 | $8.5M | -42% |
| Q4 2024 | $10.9M | -39% |
BH-A has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over BH-A on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BH-A Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.3% | +101K shares |
| 1 year | +6.7% | +152K shares |
| 3 years | +6.7% | +152K shares |
| 5 years | +6.7% | +152K shares |
| Available history | +6.7% | +152K shares |
BH-A has 2M diluted shares, up 6.7% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BH-A Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.2x | Very low |
BH-A has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BH-A Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.3 | Neutral |
| Stochastic | 25.6 | Neutral |
BH-A's weekly RSI is 49 (neutral) and its Stochastic is 26 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BH-A PE vs Consumer Cyclical Sector
| Metric | BH-A | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BH-A has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BH-A on trend strength, trading above more of its moving averages.
BH-A Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,829.6 | 1.7% below |
| 20 week MA | $1,880.4 | 4.3% below |
| 50 week MA | $1,828.3 | 1.6% below |
| 100 week MA | $1,583.3 | 14% above |
| 200 week MA | $1,237.4 | 45% above |
BH-A has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 45% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BH-A on returns for 2026, with the stronger performance.
BH-A Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $599.0 | $630.0 | +5.2% |
| 2021 | $630.0 | $718.7 | +14% |
| 2022 | $718.7 | $687.8 | -4.3% |
| 2023 | $687.8 | $793.9 | +15% |
| 2024 | $793.9 | $1,268.3 | +60% |
| 2025 | $1,268.3 | $1,841.0 | +45% |
| 2026 YTD | $1,841.0 | $1,799.0 | -2.3% |
BH-A has finished higher in five of the last six years. It's down 2.3% so far in 2026.